oxprenolol has been researched along with Recrudescence in 4 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Staessen, J | 1 |
| Bulpitt, C | 1 |
| Cattaert, A | 1 |
| Fagard, R | 1 |
| Vanhees, L | 1 |
| Amery, A | 1 |
| Taylor, SH | 1 |
| Silke, B | 1 |
| Ebbutt, A | 1 |
| Sutton, GC | 1 |
| Prout, BJ | 1 |
| Burley, DM | 1 |
4 trials available for oxprenolol and Recrudescence
| Article | Year |
|---|---|
Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Myoc | 1982 |
European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Europe; Fem | 1984 |
A long-term prevention study with oxprenolol in coronary heart disease.
Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Male; Middle A | 1982 |
European infarction study (EIS). A secondary prevention study with slow release oxprenolol after myocardial infarction.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Electrocard | 1982 |